View Author
stent patient group study lesion trial neointimal hyperplasia stent thrombosis infarction neointimal follow-up procedure month point end point difference thrombosis hyperplasia everolimus-stent group plaque burden event artery vessel medicine downloaded revascularization england journal erasmus university in-stent everolimus-eluting death peristent analysis value zotarolimus-stent group restenosi circulation cause paclitaxel-eluting zotarolimus-eluting table plaque incidence 12 months angiographic result burden 6- month follow-up taxus ii trial e ng l university target-lesion end points zotarolimu zotarolimus-stent everolimus-stent nejm.org 13 months response hospital erasmu diameter society massachusett paclitaxel serruy copyright intravascular everolimu definition study stent ultrasound zotarolimus-eluting stent right 3 groups stent implantation everolimus-eluting stent www.nejm.org polymer downloaded journal
2 Most Recent Publications
|
Comparison of zotarolimus-eluting and everolimus-eluting coronary stents
(Article)
Serruys, P.W.J.C. Silber, S. Klauss, V. Wijns, W. Macaya Miguel, C.M. Garot, P. DiMario, C. Manoharan, G. Kornowski, R. Ischinger, T. Bartorelli, A. Ronden, J. Garg, S.A. Geuns, R-J.M. van Richardt, G. Buszman, P. Kelbaek, H. Boven, A.J. Hofma, S.H. Linke, A. |
2010-07-01
|
|
Chronic arterial responses to polymer-controlled paclitaxel-eluting stents: comparison with bare metal stents by serial intravascular ultrasound analyses: data from the randomized TAXUS-II trial.
(Article)
Tanabe, K. Serruys, P.W.J.C. Kelbaek, H. Ormiston, J.A. Dawkins, K.D. Roy, L. Strauss, B.H. Disco, C. Koglin, J. Russell, M.E. Colombo, A. Degertekin, M. Guagliumi, G. Grube, E. Chan, C. Munzel, T. Belardi, J.A. Ruzyllo, W. Bilodeau, L. |
2004-01-20
|